In Jersey City, New Jersey on June 18, 2026, WallachBeth Capital LLC revealed details about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW). The latter is a prominent biotechnology firm concentrating on the development of noninvasive solutions.